Mgso4 as Neuroprotective in Post Traumatic Brain Injury

• Status: Completed
• Trial end date: 2020-06-02
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to assess the potential role of magnesium sulphate (MgSo4) as a neuroprotective agent using the Glasgow outcome scale following moderate and severe traumatic brain injury.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Osama Mohamed Abdelwahab
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• 1) Patients with moderate (GCS = 9-12), or severe (GCS = 3-8) traumatic brain injury.

2) Age above 12 years.

3) Consenting for treatment within 24 hours of trauma.

Exclusion Criteria:

• 1) Non consenting patients.

2) Persistent hypotension (BP below 90 / 60) in 1st 24 hours despite measures of resuscitation.

3) Significant multisystem association (e.g. cord injury with spinal shock).

4) Known case of renal failure